International Women’s Day: Why Women Deserve Better Genomic Medicine
Every year on March 8, the world pauses for International Women’s Day to recognize women’s achievements and call for greater equity. In healthcare, one of the most powerful frontiers for equity is genomics—using a woman’s own DNA to understand her unique risks, responses to treatment, and paths to resilience.
The research gap in women’s health
For decades, women have been under‑represented in clinical trials and biomedical research. Many conditions that affect only or mostly women—like endometriosis, PCOS, infertility, and pregnancy complications—are still poorly understood, often diagnosed late, and treated with trial‑and‑error.
Recent genomic research is beginning to change that. A large study analyzing genetic data from hundreds of thousands of women has mapped variants linked to more than 40 female reproductive conditions, including endometriosis, ovarian cysts, uterine fibroids, and pregnancy disorders like preeclampsia and intrahepatic cholestasis of pregnancy. These insights are helping us see that what we used to call “unexplained” is often just “not yet decoded.”
How genomics is reshaping women’s health
Genomics looks at how a woman’s genes influence:
Hormones and fertility – Variants can affect ovulation, how ovaries respond to FSH and LH, risk for PCOS, and likelihood of IVF success or implantation failure.
Estrogen metabolism and breast risk – Genes involved in estrogen breakdown can raise or lower risk for estrogen‑sensitive conditions, influencing how we approach hormone therapy at perimenopause and beyond.
Pregnancy and complications – Genetic risk scores can help predict susceptibility to pregnancy complications like intrahepatic cholestasis of pregnancy, enabling earlier monitoring and intervention.
Bone and cardiovascular health – Variants can influence bone density, lipid metabolism, and inflammation, helping guide prevention of osteoporosis and heart disease—two major issues for women as they age.
Instead of giving every woman the same protocol, genomics lets us ask: What does this particular woman’s biology need?
From “one‑size‑fits‑all” to precision care
At Resilient Health Austin, we already practice functional and integrative medicine that looks for root causes and sees the body as an interconnected system. Genomics adds another layer of precision to that model.
In our clinic, a genomic‑informed women’s health visit may include:
Mapping nutrient pathways (like vitamin A, omega‑3s, methylation, magnesium) that impact fertility, pregnancy, mood, skin, and energy.
Evaluating genes that influence hormone receptors and detox pathways before starting hormone replacement therapy.
Assessing risk patterns for conditions like PCOS, endometriosis, or early osteoporosis and creating proactive, personalized plans for prevention.
This doesn’t replace careful history, lab work, or imaging—it enhances them. Genomics helps explain why two women with the same diagnosis may need very different strategies.
A lifespan view: women’s health in 3 stages
1. Early adulthood and fertility planning
Genomics can highlight risks for PCOS, endometriosis, recurrent loss, and hormone imbalance long before a woman is ready for pregnancy. This opens the door to years of proactive work on inflammation, nutrient status, and hormonal health—rather than crisis management in her late 30s.
2. Pregnancy and postpartum
Understanding clotting tendencies, nutrient transport, immune tolerance, and liver metabolism can guide safer, more tailored care in pregnancy and the “fourth trimester.” For some women, these insights mean the difference between repeated losses and a healthy full‑term delivery.
3. Perimenopause, menopause, and longevity
Genomics can inform decisions about if, when, and how to use hormone therapy, and what kind of monitoring is most important. It also helps target strategies for bone, brain, and cardiovascular health—major drivers of quality of life and independence in later years.
A call to action for women and for medicine
International Women’s Day grew out of women organizing for fair work, voice, and rights. In 2026, part of that legacy is the right to fair, data‑driven, personalized healthcare that takes women’s biology seriously.
For women, that means:
Your symptoms are real, even when standard labs are “normal.”
Your genetics are not destiny—but they are powerful information.
You deserve care that sees you as an individual, not a protocol.
For medicine and technology, it means:
Investing in genomics research that reflects the diversity of women’s bodies and backgrounds.
Building tools that integrate genetics with lifestyle, environment, and lived experience—not just adding another test.
At Resilient Health Austin, we’re committed to advancing this kind of precision, whole‑person care for women at every stage of life.
If you’d like to explore how genomics could inform your own health, fertility, or menopause journey, our team would be honored to walk that path with you.